Total Payments
$1.1M
2024 Payments
$236,138
Companies
32
Transactions
2,454
Payment Breakdown by Category
Other$853,509 (79.8%)
Consulting$84,303 (7.9%)
Travel$68,847 (6.4%)
Food & Beverage$62,353 (5.8%)
Education$424.28 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $853,509 | 380 | 79.8% |
| Consulting Fee | $84,303 | 33 | 7.9% |
| Travel and Lodging | $68,847 | 505 | 6.4% |
| Food and Beverage | $62,353 | 1,521 | 5.8% |
| Education | $424.28 | 15 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $298,228 | 373 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $272,660 | 516 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $94,643 | 226 | $0 (2024) |
| ITI, Inc. | $87,415 | 135 | $0 (2023) |
| Axsome Therapeutics, Inc. | $68,555 | 102 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $55,779 | 194 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $47,399 | 88 | $0 (2024) |
| ABBVIE INC. | $36,757 | 135 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $20,124 | 66 | $0 (2022) |
| Takeda Pharmaceuticals America, Inc. | $19,314 | 27 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $236,138 | 435 | Axsome Therapeutics, Inc. ($50,486) |
| 2023 | $238,675 | 455 | Otsuka America Pharmaceutical, Inc. ($60,902) |
| 2022 | $147,992 | 329 | Alkermes, Inc. ($49,879) |
| 2021 | $60,207 | 192 | Alkermes, Inc. ($30,956) |
| 2020 | $43,161 | 154 | Alkermes, Inc. ($22,631) |
| 2019 | $130,413 | 349 | Alkermes, Inc. ($53,074) |
| 2018 | $113,187 | 299 | Takeda Pharmaceuticals U.S.A., Inc. ($32,512) |
| 2017 | $99,665 | 241 | Otsuka America Pharmaceutical, Inc. ($37,959) |
All Payment Transactions
2,454 individual payment records from CMS Open Payments — Page 1 of 99
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $33.36 | General |
| Category: Neuropsychiatry | ||||||
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: Neurology | ||||||
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Travel and Lodging | Cash or cash equivalent | $68.26 | General |
| Category: Neurology | ||||||
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $41.34 | General |
| Category: Neurology | ||||||
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $36.82 | General |
| Category: Central Nervous System | ||||||
| 12/18/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.47 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,630.00 | General |
| Category: CNS | ||||||
| 12/11/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Travel and Lodging | In-kind items and services | $201.45 | General |
| Category: CNS | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.26 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Neuropsychiatry | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Travel and Lodging | Cash or cash equivalent | $208.54 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $140.15 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/02/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: CNS | ||||||
| 11/28/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.20 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Neuropsychiatry | ||||||
| 11/26/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $103.02 | General |
| Category: CNS | ||||||
| 11/25/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Central Nervous System | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $21.53 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/08/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Travel and Lodging | Cash or cash equivalent | $94.43 | General |
| Category: PSYCHIATRY | ||||||
About Dr. Jianping Chen, M.D
Dr. Jianping Chen, M.D is a Psychiatry healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245229814.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jianping Chen, M.D has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $236,138 received in 2024. These payments were reported across 2,454 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($853,509).
Ad
Practice Information
- Specialty Psychiatry
- Location New York, NY
- Active Since 10/17/2005
- Last Updated 06/23/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1245229814
Products in Payments
- REXULTI (Drug) $162,437
- ARISTADA (Drug) $135,846
- CAPLYTA (Drug) $134,814
- LYBALVI (Drug) $95,412
- ABILIFY MAINTENA (Drug) $95,218
- Trintellix (Drug) $73,580
- Auvelity (Drug) $68,555
- Aristada 441 mg (Drug) $66,845
- UZEDY (Drug) $41,557
- VRAYLAR (Drug) $37,122
- Austedo XR (Drug) $35,200
- LATUDA (Drug) $20,124
- FANAPT (Drug) $17,408
- ABILIFY ASIMTUFII (Drug) $16,547
- AUSTEDO (Drug) $16,305
- QUVIVIQ (Drug) $15,805
- PERSERIS (Drug) $13,826
- INGREZZA (Drug) $9,214
- TRINTELLIX (Drug) $2,411
- BRINTELLIX (Drug) $626.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in New York
Dr. Manish Zinzuvadia, M.d, M.D
Psychiatry — Payments: $1.3M
Psychiatry $1.3M
Dr. Ulla Laakso, Md, MD
Psychiatry — Payments: $957,236
Psychiatry $957,236
Dr. Kerry Sulkowicz, M.d, M.D
Psychiatry — Payments: $476,134
Psychiatry $476,134
Dr. Ralph Aquila, M.d, M.D
Psychiatry — Payments: $327,213
Psychiatry $327,213
Dr. Paul Eder, M.d, M.D
Psychiatry — Payments: $278,989
Psychiatry $278,989
Leonardo Vando, Md, MD
Psychiatry — Payments: $265,745
Psychiatry $265,745